We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Common Herbs Found to Improve Memory and Learning Capabilities

By LabMedica International staff writers
Posted on 04 Dec 2013
Enhanced extracts made from special antioxidants in spearmint and rosemary have been found to improve learning and memory, according to new lab research.

“We found that these proprietary compounds reduce deficits caused by mild cognitive impairment, which can be a precursor to Alzheimer’s disease,” said Susan Farr, PhD, research professor geriatrics at Saint Louis University School of Medicine (MO, USA). More...
“This probably means eating spearmint and rosemary is good for you. However, our experiments were in an animal model and I don’t know how much—or if any amount—of these herbs people would have to consume for learning and memory to improve. In other words, I’m not suggesting that people chew more gum at this point.”

Dr. Farr presented her earlier findings at Neuroscience 2013, a meeting held in San Diego, CA, USA, on November 11, 2103. She evaluated a unique antioxidant-based compound made from spearmint extract and two different doses of a similar antioxidant made from rosemary extract on mice that have age-related cognitive decline. She discovered that the higher dose rosemary-extract compound was the most powerful in improving memory and learning in three evaluated behaviors. The lower dose rosemary extract enhanced memory in two of the behavioral tests, as did the compound derived from spearmint extract.

Furthermore, there were signs of reduced oxidative stress, which is considered a hallmark of age-related decline, in the part of the brain that controls learning and memory. “Our research suggests these extracts made from herbs might have beneficial effects on altering the course of age-associated cognitive decline,” Dr. Farr said. “It’s worth additional study.”

Related Links:

Saint Louis University School of Medicine



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
Urine Analyzer
respons® UDS100
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: MCD tests are designed to detect multiple cancers from a single blood sample, but the statements note that evaluating these assays is far more complex than assessing single-cancer tests (image credit: Adobe Stock)

Position Statements Outline Evidence Standards for Multi-Cancer Detection Tests

Cancer screening is intended to reduce mortality, but policy decisions often depend on early indicators that may not fully reflect true survival benefit. The emergence of blood-based tests capable of detecting... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.